Horne, Anne M <br/><br/>
Bone Loss After Romosozumab/Denosumab: Effects of Bisphosphonates.  [electronic resource] 

 -  Calcified tissue international  07 2018 
 - 55-61 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1432-0827 
<br/><br/><label>Standard No.: </label>10.1007/s00223-018-0404-6  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antibodies, Monoclonal--administration & dosage<br/>Bone Density--drug effects<br/>Bone Density Conservation Agents--therapeutic use<br/>Bone Remodeling--drug effects<br/>Clinical Trials, Phase III as Topic<br/>Denosumab--administration & dosage<br/>Diphosphonates--administration & dosage<br/>Female<br/>Humans<br/>Middle Aged<br/>Osteoporosis, Postmenopausal--drug therapy<br/>Randomized Controlled Trials as Topic<br/>Risedronic Acid--administration & dosage<br/>Zoledronic Acid--administration & dosage